Details for New Drug Application (NDA): 206197
✉ Email this page to a colleague
The generic ingredient in FOSAPREPITANT DIMEGLUMINE is fosaprepitant dimeglumine. There are eleven drug master file entries for this compound. Twenty-four suppliers are listed for this compound. Additional details are available on the fosaprepitant dimeglumine profile page.
Summary for 206197
Tradename: | FOSAPREPITANT DIMEGLUMINE |
Applicant: | Fresenius Kabi Usa |
Ingredient: | fosaprepitant dimeglumine |
Patents: | 0 |
Suppliers and Packaging for NDA: 206197
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
FOSAPREPITANT DIMEGLUMINE | fosaprepitant dimeglumine | POWDER;INTRAVENOUS | 206197 | ANDA | Fresenius Kabi USA, LLC | 63323-972 | 63323-972-10 | 1 VIAL, SINGLE-DOSE in 1 CARTON (63323-972-10) / 10 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 150MG BASE/VIAL | ||||
Approval Date: | Jun 9, 2016 | TE: | AP | RLD: | No |
Complete Access Available with Subscription